logo

0.5201

0.52 (-8.56%)

As of Jun 14, 2022

Nrx Pharmaceuticals, Inc. [NRXP]

Source: 

Company Overview

NRx is a clinical-stage pharmaceutical company which develops, through its wholly-owned operating subsidiary, NeuroRx, Inc., novel therapeutics for the treatment of central nervous system disorders. Our strategy is to apply innovative science to known molecules in the pursuit of therapies for high unmet needs, including lethal conditions.

CountryUnited States
Headquarterswilmingtondelaware
Phone Number484-254-6134
Industry
finance
CEOStephen H. Willard
Website

Related Stories